Skip to main content

Advertisement

Table 2 Characteristics of ovarian cancer patients, N = 5,213.

From: The impact of comorbidity and stage on ovarian cancer mortality: A nationwide Danish cohort study

  Charlson Comorbidity score
  Comorbidity 0 Comorbidity 1–2 Comorbidity 3+
Number 3,727 (72%) 1,116 (21%) 370 (7%)
Median age, years 62 70 71
(25% – 75% percentile) (52–72) (59–77) (62–78)
Age groups    
   < 50 years 726 (19%) 96 (9%) 21 (6%)
   50–69 years 1,897 (51%) 474 (42%) 153 (41%)
   70–89 years 1,079 (29%) 521 (47%) 188 (51%)
   90+ years 25 (< 1%) 25 (2%) 8 (2%)
Year of diagnosis    
   1995–1997 1,278 (74%) 336 (19%) 119 (7%)
   1998–2000 1,300 (71%) 406 (22%) 119 (7%)
   2001–2003 1,149 (69%) 374 (23%) 132 (8%)
Extent of cancer    
   Localized/FIGO I 774 (21%) 184 (16%) 37 (10%)
   Regional/FIGO II and III 1,757 (47%) 492 (44%) 157 (42%)
   Distant metastases/FIGO IV 1,002 (27%) 338 (30%) 140 (38%)
   Unspecified/missing 194 (5%) 102 (9%) 36 (10%)
Histological type    
   Epithelial 3,422 (92%) 985 (88%) 322 (87%)
   Non-epithelial 305 (8%) 131 (12%) 48 (13%)
Treatment    
   Surgery/Chemotherapy 1,753 (47%) 378 (34%) 101 (27%)
   Surgery 1,416 (38%) 442 (40%) 132 (36%)
   Chemotherapy 230 (6%) 94 (8%) 32 (9%)
   Other* 12 (< 1%) 9 (< 1%) 6 (2%)
   No/Symptomatic 285 (8%) 178 (16%) 94 (25%)
   Missing 31 (< 1%) 15 (1%) 5 (1%)
  1. *Hormonal treatment, radiation, other not specified